How Well Does A New Alzheimer's Drug Work For...

For years, renewable energy companies have faced a problem: How to store the mass amounts of energy they produce for later use. Batteries may be just the solution. In California, there's now enough grid-scale battery storage to power millions of homes for a few hours. Battery pow ...  Show more

Nearly every person will experience at least one diagnostic error in their lifetime. That means either a delayed diagnosis, a wrong diagnosis – or no diagnosis at all. That’s according to a report by the National Academies of Sciences, Engineering and Medicine from 2015 on diagno ...  Show more

When the F.D.A. approved the drug Aduhelm, the first Alzheimer’s treatment to receive the agency’s endorsement in almost two decades, it gave hope to many.

But the decision was contentious; some experts say there’s not enough evidence that the treatment can address cogni ...

Last year, researchers announced that the Alzheimer’s drug lecanemab lowered the amount of amyloid protein plaques associated with the disease in the brains of participants in a clinical trial, and slowed their cognitive decline.Now, researchers are looking to drug combinations, ...  Show more

A new drug, Donanemab, has been hailed as a turning point in the fight against Alzheimer's after a global trial confirms it slows cognitive decline.One trial was shown to have “significantly slowed” the progression of the disease—by 35%.Earlier this year, Lecanemab, the first dru ...  Show more

Until recently, breakthroughs in treating Alzheimer’s disease were non-existent. But two new drugs have shown promise in moderately slowing memory and thinking problems for people with early-stage disease. While welcoming the idea of a ‘new era’ for treating Alzheimer’s disease, ...  Show more